BioXcel Therapeutics (BTAI) Current Assets (2022 - 2025)
Historic Current Assets for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $44.4 million.
- BioXcel Therapeutics' Current Assets fell 709.11% to $44.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.4 million, marking a year-over-year decrease of 709.11%. This contributed to the annual value of $37.4 million for FY2024, which is 4816.68% down from last year.
- Latest data reveals that BioXcel Therapeutics reported Current Assets of $44.4 million as of Q3 2025, which was down 709.11% from $25.2 million recorded in Q2 2025.
- In the past 5 years, BioXcel Therapeutics' Current Assets ranged from a high of $244.9 million in Q2 2022 and a low of $25.2 million during Q2 2025
- Its 4-year average for Current Assets is $114.7 million, with a median of $80.9 million in 2024.
- As far as peak fluctuations go, BioXcel Therapeutics' Current Assets tumbled by 6443.85% in 2023, and later crashed by 709.11% in 2025.
- Over the past 4 years, BioXcel Therapeutics' Current Assets (Quarter) stood at $202.9 million in 2022, then tumbled by 64.44% to $72.1 million in 2023, then plummeted by 48.17% to $37.4 million in 2024, then rose by 18.74% to $44.4 million in 2025.
- Its Current Assets was $44.4 million in Q3 2025, compared to $25.2 million in Q2 2025 and $37.8 million in Q1 2025.